Anticoagulant Management for NVAF: Burden on Healthcare Systems
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First At-Home Treatment Device for Depression
2
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
3
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
4
ADCs in Breast Cancer: Shaping the Future of HER2 and TROP-2 Targeted Therapy
5
